Bradycor SB-238592 bradykinin antagonist: Phase II trial

Cortech Inc. (CRTQ), Denver, Colo.
Product: Bradycor SB-238592 bradykinin

Read the full 92 word article

How to gain access

Continue reading with a
two-week free trial.